AnalystsElemer PirosElemer Piros's Stock Forecasts
AnalystsElemer Piros
Analyst Ranking
Bottom 18%
#4017 out of 4873 analysts
Average Return
-0.45%
Win Rate
30%34 out of 113
Risk vs Reward
Poor
Good
Elemer Piros's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Monopar TherapeuticsMNPR | +670.36% | $5.50 | $42.37 | 2024-10-10 - 2025-05-08 | Strong Buy |
Arrowhead Pharmaceuticals IncARWR | +371.70% | $13.96 | $65.85 | 2018-12-16 - 2019-12-17 | Strong Buy |
Mind Medicine IncMNMD | +222.26% | $3.01 | $9.70 | 2023-03-09 - 2024-03-08 | Strong Buy |
Mind Medicine IncMNMD | +206.01% | $3.16 | $9.67 | 2023-04-13 - 2024-04-12 | Strong Buy |
Mind Medicine IncMNMD | +193.26% | $3.41 | $10.00 | 2023-05-04 - 2024-05-03 | Strong Buy |
Elemer Piros Analyst Color
Get additional color on Elemer Piros's coverage of popular stocks
Elemer Piros's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Bioxcel Therapeutics IncBTAI | 1 | Strong Buy | $65.00 | +4,013.92% | Initiates Coverage On | 2 months ago |
Fibrobiologics IncFBLG | 1 | Strong Buy | $12.00 | +1,318.44% | Initiates Coverage On | 5 months ago |
Tharimmune IncTHAR | 1 | Strong Buy | $17.00 | +1,040.94% | Initiates Coverage On | 5 months ago |
Quince Therapeutics IncQNCX | 1 | Strong Buy | $11.00 | +967.96% | Initiates Coverage On | 6 months ago |
Monopar TherapeuticsMNPR | 6 | Strong Buy | $50.00 | +18.01% | Initiates Coverage On | 7 months ago |
Mira Pharmaceuticals IncMIRA | 1 | Strong Buy | $17.00 | +1,260.00% | Initiates Coverage On | 7 months ago |
Athira Pharma IncATHA | 1 | Strong Buy | $22.00 | +8,139.70% | Initiates Coverage On | 9 months ago |
Cassava Sciences IncSAVA | 1 | Strong Buy | $107.00 | +6,194.12% | Reiterates | 9 months ago |
Cognition Therapeutics IncCGTX | 1 | Strong Buy | $14.00 | +4,142.42% | Reiterates | 10 months ago |
Annovis Bio IncANVS | 1 | Strong Buy | $67.00 | +4,087.50% | Reiterates | 10 months ago |
Alto Neuroscience IncANRO | 1 | Strong Buy | $43.00 | +1,863.47% | Initiates Coverage On | a year ago |
Coya Therapeutics IncCOYA | 7 | Strong Buy | $18.00 | +189.86% | Initiates Coverage On | a year ago |
Hoth Therapeutics IncHOTH | 3 | Strong Buy | $7.50 | N/A | Maintains | 2 years ago |
Atai Life Sciences NvATAI | 8 | Strong Buy | $15.00 | N/A | Reiterates | 2 years ago |
Mind Medicine IncMNMD | 8 | Strong Buy | $21.00 | N/A | Reiterates | 2 years ago |
Compass Pathways PLCCMPS | 9 | Strong Buy | $38.00 | N/A | Reiterates | 2 years ago |
Pasithea Therapeutics CorpKTTA | 2 | Strong Buy | $40.00 | N/A | Reiterates | 2 years ago |
Unicycive Therapeutics IncUNCY | 5 | Strong Buy | $5.00 | N/A | Reiterates | 2 years ago |
Cybin IncCYBN | 3 | Strong Buy | $114.00 | N/A | Reiterates | 2 years ago |
Clene IncCLNN | 6 | Strong Buy | $200.00 | N/A | Maintains | 2 years ago |
Opthea LtdOPT | 2 | Strong Buy | $23.00 | N/A | Reiterates | 2 years ago |
Gh Research PLCGHRS | 3 | Strong Buy | $33.00 | N/A | Reiterates | 2 years ago |
Reunion Neuroscience IncREUN | 2 | Strong Buy | $11.00 | N/A | Reiterates | 2 years ago |
Apellis Pharmaceuticals IncAPLS | 6 | Strong Sell | $40.00 | N/A | Downgrades | 3 years ago |
Unity Biotechnology IncUBX | 3 | Strong Buy | $40.00 | N/A | Upgrades | 3 years ago |
Biorestorative Therapies IncBRTX | 1 | Strong Buy | $37.00 | N/A | Initiates Coverage On | 3 years ago |
Diamedica Therapeutics IncDMAC | 2 | Strong Buy | $32.00 | N/A | Maintains | 4 years ago |
Global Blood Therapeutics IncGBT | 5 | Strong Buy | $124.00 | N/A | Maintains | 4 years ago |
Durect CorpDRRX | 1 | Strong Buy | $70.00 | N/A | Initiates Coverage On | 5 years ago |
Cohbar IncCWBR | 1 | Strong Buy | $240.00 | N/A | Initiates Coverage On | 5 years ago |
Arcturus Therapeutics Holdings IncARCT | 1 | Strong Buy | $77.00 | N/A | Reinstates | 5 years ago |
Polarityte IncPTEIQ | 2 | Strong Buy | $75.00 | N/A | Maintains | 5 years ago |
Intercept Pharmaceuticals IncICPT | 3 | Strong Buy | $191.00 | N/A | Reiterates | 6 years ago |
Spark Therapeutics IncONCE | 2 | Hold | $114.50 | N/A | Downgrades | 6 years ago |
Arrowhead Pharmaceuticals IncARWR | 3 | Strong Buy | $165.00 | N/A | Maintains | 6 years ago |
Zynerba Pharmaceuticals IncZYNE | 2 | Strong Buy | $21.00 | N/A | Initiates Coverage On | 7 years ago |
Corbus Pharmaceuticals Holdings IncCRBP | 4 | Strong Buy | $1,080.00 | N/A | Maintains | 7 years ago |
Krystal Biotech IncKRYS | 1 | Strong Buy | $28.00 | N/A | Initiates Coverage On | 7 years ago |
Strongbridge Biopharma PLCSBBP | 2 | Strong Buy | $17.00 | N/A | Maintains | 7 years ago |
Corner Growth Acquisition CorpCOOL | 1 | Strong Buy | $65.00 | N/A | Maintains | 7 years ago |
Dynavax Technologies CorpDVAX | 2 | Strong Buy | $250.00 | N/A | Maintains | 7 years ago |
Aldeyra Therapeutics IncALDX | 1 | Strong Buy | $22.00 | N/A | Initiates Coverage On | 8 years ago |
Abeona Therapeutics IncABEO | 1 | Strong Buy | $850.00 | N/A | Maintains | 8 years ago |
Ocular Therapeutix IncOCUL | 1 | Strong Buy | $21.00 | N/A | Maintains | 8 years ago |
Omeros CorpOMER | 1 | Hold | $15.00 | N/A | Downgrades | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.